← Every company
BioCryst Pharmaceuticals Inc SEC Filings
What BioCryst Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BCRX overview →Filings on file
154
since Sep 26, 2016
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jun 12, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 23, 2026 | Executive or director change 8-K/A | Read ↗ |
| Dec 11, 2025 | Executive or director change 8-K | Read ↗ |
| Oct 14, 2025 | Executive or director changeResults announcedMaterial agreement 8-K | Read ↗ |
| Aug 11, 2025 | Executive or director change 8-K | Read ↗ |
| Jul 31, 2025 | Executive or director change 8-K | Read ↗ |
| Jul 7, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 16, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jun 4, 2025 | Executive or director change 8-K | Read ↗ |
| May 1, 2025 | Executive or director change 8-K | Read ↗ |
| Apr 10, 2025 | Executive or director change 8-K | Read ↗ |
| Mar 4, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 13, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Dec 1, 2023 | Executive or director change 8-K | Read ↗ |
| Jul 11, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 14, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Sep 14, 2022 | Executive or director change 8-K | Read ↗ |
| Jun 7, 2022 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 8, 2022 | Executive or director change 8-K | Read ↗ |
| Sep 20, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 26, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 9, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 3, 2021 | Executive or director change 8-K | Read ↗ |
| Jul 28, 2021 | Executive or director change 8-K | Read ↗ |
| May 26, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Dec 17, 2020 | Executive or director change 8-K | Read ↗ |
| May 13, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 2, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 25, 2020 | Executive or director change 8-K | Read ↗ |
| Jan 13, 2020 | Executive or director change 8-K | Read ↗ |
| Nov 8, 2019 | Executive or director change 8-K | Read ↗ |
| Sep 23, 2019 | Executive or director change 8-K | Read ↗ |
| Jul 1, 2019 | Executive or director change 8-K | Read ↗ |
| Jul 1, 2019 | Executive or director change 8-K | Read ↗ |
| Jun 4, 2019 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jan 4, 2019 | Executive or director change 8-K | Read ↗ |
| Nov 20, 2018 | Executive or director change 8-K | Read ↗ |
| Oct 31, 2018 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 30, 2017 | Executive or director changeShareholder vote 8-K | Read ↗ |
Source: BioCryst Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BCRX
Company overviewEverything on BCRX in one place, with the price.Insider tradingWhat BCRX's own officers and directors buy and sell.Executive payWhat BCRX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in BCRX.Funds holding itWhich funds and ETFs hold BCRX, and how big a bet.Federal contractsWhat federal agencies pay BCRX.PatentsWhat BCRX is filing at the patent office.